Literature DB >> 14632657

Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire.

Alessandra Battaglia1, Gabriella Ferrandina, Alessia Buzzonetti, Paolo Malinconico, Francesco Legge, Vanda Salutari, Giovanni Scambia, Andrea Fattorossi.   

Abstract

Here we provide a description of lymphocyte populations in human lymph nodes (LN) with a special emphasis on the CD4+ lymphocyte population constitutively expressing CD25 at a high level and endowed with immunoregulatory properties [T regulatory (Treg) cells]. Lymph nodes were analysed by multicolour flow cytometry in parallel with correspondent peripheral blood (PB). Immunomagnetically purified Treg cells were tested for anergy and suppressive activity in a CD3/T-cell receptor (TCR)-driven proliferation assay. Compared to PB, there was a reduced T/B lymphocyte ratio in LN. Both LN and PB contained a similar proportion of CD4+ lymphocytes but, conversely, CD8+ lymphocytes were less represented in PB, with a consequent increase in the ratio of CD4+/CD8+ natural killer cells were <2% (PB range 6-22%). No significant differences existed in the frequency of the other lymphocyte subpopulations examined (naïve-type CD4+ and CD8+ lymphocytes, activated B and CD4+ lymphocytes, and effector-type CD8+ lymphocytes). LN and PB contained similar percentages of CD4+ lymphocytes constitutively expressing intermediate or high levels of CD25. CD4+ CD25++ cells constitutively coexpressed high levels of CD152 and were therefore identified as Treg cells. Treg cells in LN and PB differed in terms of CD45RB, HLA-DR, CD45RO, and CD62L expression. Also the TCRVbeta repertoire diverged between Treg cells from LN and PB. Similar to Treg cells from PB, Treg cells from LN were anergic and efficiently inhibited other CD4+ and CD8+ lymphocyte proliferation. This study extends the information on the diversities in lymphocyte composition between human LN and PB, and reports for the first time a description of the phenotypic and functional characteristics of Treg cells in human LN, highlighting the importance of the LN microenvironment in shaping the surface phenotype of Treg cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632657      PMCID: PMC1783055          DOI: 10.1046/j.1365-2567.2003.01742.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

Review 1.  Regulatory T cells in transplantation.

Authors:  Mahzuz Karim; Andrew R Bushell; Kathryn J Wood
Journal:  Curr Opin Immunol       Date:  2002-10       Impact factor: 7.486

2.  Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Authors:  E Y Woo; C S Chu; T J Goletz; K Schlienger; H Yeh; G Coukos; S C Rubin; L R Kaiser; C H June
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 4.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

5.  Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Paolo Malinconico; Andrea Stoler; Leila Andreocci; Dino Parente; Annamaria Coscarella; Nicola Maggiano; Alessandro Perillo; Luca Pierelli; Giovanni Scambia
Journal:  Exp Cell Res       Date:  2002-10-15       Impact factor: 3.905

6.  Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood.

Authors:  Kajsa Wing; Ann Ekmark; Helen Karlsson; Anna Rudin; Elisabeth Suri-Payer
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

7.  CD4+CD25+ T lymphocytes in human tonsils suppress the proliferation of CD4+CD25- tonsil cells.

Authors:  C Simark-Mattsson; U Dahlgren; K Roos
Journal:  Scand J Immunol       Date:  2002-06       Impact factor: 3.487

Review 8.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

9.  Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.

Authors:  Udaya K Liyanage; Todd T Moore; Hong-Gu Joo; Yoshiyuki Tanaka; Virginia Herrmann; Gerard Doherty; Jeffrey A Drebin; Steven M Strasberg; Timothy J Eberlein; Peter S Goedegebuure; David C Linehan
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

10.  Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Francesco Liotta; Elena Lazzeri; Roberto Manetti; Vittorio Vanini; Paola Romagnani; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  20 in total

Review 1.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

2.  Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Alexia Buzzonetti; Francesca Ciaraffa; Giovanni Scambia; Amelia Evoli
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

3.  Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys.

Authors:  M R L Marco; E M Dons; D J van der Windt; J K Bhama; L T Lu; A F Zahorchak; F G Lakkis; D K C Cooper; M B Ezzelarab; A W Thomson
Journal:  Transpl Immunol       Date:  2013-10-09       Impact factor: 1.708

4.  Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients.

Authors:  Hansol Lee; Camelia Quek; Ines Silva; Annie Tasker; Marcel Batten; Helen Rizos; Su Yin Lim; Tuba Nur Gide; Ping Shang; Grace H Attrill; Jason Madore; Jarem Edwards; Matteo S Carlino; Alexander Guminski; Robyn P M Saw; John F Thompson; Peter M Ferguson; Umaimainthan Palendira; Alexander M Menzies; Georgina V Long; Richard A Scolyer; James S Wilmott
Journal:  Oncoimmunology       Date:  2018-10-31       Impact factor: 8.110

Review 5.  Linking autoantigen properties to mechanisms of immunity.

Authors:  J Daniel Griffin; Jimmy Y Song; Joshua O Sestak; Brandon J DeKosky; Cory J Berkland
Journal:  Adv Drug Deliv Rev       Date:  2020-04-20       Impact factor: 15.470

6.  Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Ruth-Anne Langan; Alberto Sada Japp; Helen L Partridge; Sheila K Pierson; Amrit Singh; Daniel J Arenas; Jason R Ruth; Christopher S Nabel; Katie Stone; Mariko Okumura; Anthony Schwarer; Fábio Freire Jose; Nelson Hamerschlak; Gerald B Wertheim; Michael B Jordan; Adam D Cohen; Vera Krymskaya; Arthur Rubenstein; Michael R Betts; Taku Kambayashi; Frits van Rhee; Thomas S Uldrick
Journal:  J Clin Invest       Date:  2019-08-13       Impact factor: 14.808

7.  Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses.

Authors:  Max Rieckmann; Murilo Delgobo; Chiara Gaal; Lotte Büchner; Philipp Steinau; Dan Reshef; Cristina Gil-Cruz; Ellis N Ter Horst; Malte Kircher; Theresa Reiter; Katrin G Heinze; Hans Wm Niessen; Paul Aj Krijnen; Anja M van der Laan; Jan J Piek; Charlotte Koch; Hans-Jürgen Wester; Constantin Lapa; Wolfgang R Bauer; Burkhard Ludewig; Nir Friedman; Stefan Frantz; Ulrich Hofmann; Gustavo Campos Ramos
Journal:  J Clin Invest       Date:  2019-08-13       Impact factor: 14.808

8.  Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.

Authors:  Alessandra Battaglia; Alexia Buzzonetti; Giovanni Monego; Laura Peri; Gabriella Ferrandina; Francesco Fanfani; Giovanni Scambia; Andrea Fattorossi
Journal:  Immunology       Date:  2007-11-20       Impact factor: 7.397

9.  Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Alexia Buzzonetti; Giacomo Minicuci; Raffaella Riso; Laura Peri; Giovanni Scambia; Amelia Evoli
Journal:  J Clin Immunol       Date:  2007-11-14       Impact factor: 8.317

10.  Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine.

Authors:  Eduardo Lasalvia-Prisco; Emilio Garcia-Giralt; Silvia Cucchi; Jesús Vázquez; Leonard Robinson; John Dalton
Journal:  Biologics       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.